An extension study to evaluate the outcomes of patients treated with extracorporeal hepatocyte based therapy

Trial Profile

An extension study to evaluate the outcomes of patients treated with extracorporeal hepatocyte based therapy

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 02 Sep 2015

At a glance

  • Drugs Extracorporeal hepatocyte-based therapy (Primary)
  • Indications Alcoholic hepatitis; Liver failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Sep 2015 New trial record
    • 31 Aug 2015 Data from this trial were presented at the 16th International Symposium on Albumin Dialysis in Liver Disease according to a Vital Therapies media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top